Home/Filings/4/0001209191-23-058715
4//SEC Filing

Goswami Trishna 4

Accession 0001209191-23-058715

CIK 0001740279other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 8:20 AM ET

Size

9.5 KB

Accession

0001209191-23-058715

Insider Transaction Report

Form 4
Period: 2023-12-13
Goswami Trishna
Chief Medical Officer
Transactions
  • Award

    Series A Warrants (right to buy)

    2023-12-13+4,0984,098 total
    Exercise: $1.25Exp: 2025-06-13Common Stock (4,098 underlying)
  • Award

    Series B Warrants (right to buy)

    2023-12-13+4,0984,098 total
    Exercise: $1.50Exp: 2028-12-13Common Stock (4,098 underlying)
  • Award

    Common Stock

    2023-12-13+4,0986,729 total
Footnotes (2)
  • [F1]The reported securities are included within 4,098 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 4,098 shares of common stock.
  • [F2]Fully vested and exercisable.

Issuer

IN8BIO, INC.

CIK 0001740279

Entity typeother

Related Parties

1
  • filerCIK 0001894243

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 8:20 AM ET
Size
9.5 KB